Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-13-040926
Filing Date
2013-11-06
Accepted
2013-11-06 17:18:42
Documents
13
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 POZEN INC 10-Q 9-30-2013 form10q.htm 10-Q 856950
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 34752
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 896522
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 12253
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 11577
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 6002
7 EXHIBIT 32.2 ex32_2.htm EX-32.2 5866
  Complete submission text file 0001140361-13-040926.txt   7724935

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT pozn-20130930.xml EX-101.INS 1125828
9 XBRL TAXONOMY EXTENSION SCHEMA pozn-20130930.xsd EX-101.SCH 29430
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pozn-20130930_cal.xml EX-101.CAL 33297
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pozn-20130930_def.xml EX-101.DEF 135856
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE pozn-20130930_lab.xml EX-101.LAB 463077
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pozn-20130930_pre.xml EX-101.PRE 246722
Mailing Address 1414 RALEIGH ROAD SUITE 400 CHAPEL HILL NC 27517
Business Address 1414 RALEIGH ROAD SUITE 400 CHAPEL HILL NC 27517 919-913-1030
POZEN INC /NC (Filer) CIK: 0001059790 (see all company filings)

EIN.: 621657552 | Fiscal Year End: 0919
Type: 10-Q | Act: 34 | File No.: 000-31719 | Film No.: 131197459
SIC: 2834 Pharmaceutical Preparations